| |
| |
|
| Insider
Information: |
Enyedy Mark J |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
33,323 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$234,945 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
33,323 |
|
|
| Total
Value |
$234,945 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 253.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Immunogen Inc |
IMGN |
CHIEF EXECUTIVE OFFICE... |
2024-02-12 |
0 |
|
0 |
Premium* |
|
|
Keryx Biopharmaceuticals Inc |
KERX |
Director |
2018-12-12 |
0 |
2018-06-30 |
0 |
Premium* |
|
|
Akebia Therapeutics, Inc. |
AKBA |
|
2020-06-05 |
31,143 |
2018-12-12 |
0 |
Premium* |
|
|
Logicbio Therapeutics, Inc. |
LOGC |
Director |
2022-11-16 |
0 |
2021-01-01 |
0 |
Premium* |
|
|
Biomarin Pharmaceutical Inc |
BMRN |
Director |
2023-12-27 |
2,180 |
2023-12-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(584,397) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-05 |
4 |
AS |
$29.28 |
$588,733 |
D/D |
(20,107) |
584,397 |
0 |
% |
|
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
51,234 |
604,504 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
Director |
– • – |
2023-12-27 |
4 |
A |
$0.00 |
$0 |
D/D |
2,180 |
2,180 |
0 |
- |
|
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-08-04 |
4 |
S |
$16.96 |
$16,831,053 |
D/D |
(992,397) |
553,270 |
0 |
% |
|
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-08-04 |
4 |
OE |
$4.55 |
$5,901,760 |
D/D |
1,104,218 |
1,545,667 |
0 |
- |
|
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-08-03 |
4 |
OE |
$4.55 |
$4,642,932 |
D/D |
1,020,000 |
1,461,449 |
0 |
- |
|
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-08-03 |
4 |
S |
$16.61 |
$16,942,200 |
D/D |
(1,020,000) |
441,449 |
0 |
% |
|
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-08-02 |
4 |
S |
$17.45 |
$17,371,535 |
D/D |
(995,157) |
441,449 |
0 |
% |
|
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-08-02 |
4 |
OE |
$4.55 |
$4,527,964 |
D/D |
995,157 |
1,436,606 |
0 |
- |
|
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2023-06-30 |
4 |
A |
$4.05 |
$21,226 |
D/D |
5,241 |
441,449 |
0 |
- |
|
| LOGC |
Logicbio Therapeutics, In... |
Director |
– • – |
2022-11-16 |
4 |
D |
$0.00 |
$0 |
D/D |
(2,921) |
0 |
0 |
- |
|
| IMGN |
Immunogen Inc |
CHIEF EXECUTIVE OFFICER |
• • – |
2022-06-30 |
4 |
A |
$3.83 |
$12,783 |
D/D |
3,342 |
436,208 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2021-06-30 |
4 |
A |
$5.52 |
$21,246 |
D/D |
3,849 |
432,866 |
0 |
- |
|
| LOGC |
Logicbio Therapeutics, In... |
Director |
– • – |
2021-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,921 |
2,921 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2020-12-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
429,017 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2020-06-30 |
4 |
A |
$3.91 |
$20,492 |
D/D |
5,241 |
439,017 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
31,143 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2020-02-24 |
4 |
AS |
$4.99 |
$275,558 |
D/D |
(55,222) |
433,776 |
0 |
% |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2019-07-01 |
4 |
A |
$1.84 |
$9,623 |
D/D |
5,230 |
488,998 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
|
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
13,700 |
17,443 |
0 |
- |
|
| IMGN |
Immunogen Inc |
Chief Executive Officer |
• • – |
2019-01-03 |
4 |
A |
$4.08 |
$10,016 |
D/D |
2,455 |
534,838 |
0 |
- |
|
| AKBA |
Akebia Therapeutics, Inc. |
Director |
– • – |
2018-12-12 |
4 |
A |
$0.00 |
$0 |
D/D |
3,743 |
3,743 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2018-12-12 |
4 |
D |
$0.00 |
$0 |
D/D |
(10,000) |
0 |
0 |
- |
|
| KERX |
Keryx Biopharmaceuticals ... |
Director |
– • – |
2018-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
10,000 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
